Process for resolving amines that are useful for the treatment of disorders associated with insulin resistance syndrome
CA 2521879 C · Owner: Poxel Sas · Inventors: Passemar, Thierry; Cravo, Daniel; Moinet, Gerard
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention is directed towards a process for resolving a racemic amino compound derived from dihydro- 1,3,5- triazines. The invention is also directed towards the enantiomers of amino derivatives of dihydro-1,3,5triazines and to their use for the preparation of medicaments in particular , for the treatment of diabetes and malaria.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 6, 2004 and granted January 8, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 6, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 6, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.